THENA Capital

"This funding marks a defining moment for Zonova. We founded the company with the belief that infection prevention in medical devices needed a fundamentally new approach, one that moves beyond coatings, antibiotics, and short term fixes. Our technology has the potential to redefine how medical devices are designed globally by embedding antimicrobial protection directly into the material itself. THENA Capital immediately understood both the scale of the clinical problem and the magnitude of the commercial opportunity. The THENA team brings an exceptional combination of scientific depth, strategic insight, and operational ambition that is incredibly rare in venture. We are thrilled to have them leading this round and joining us as we scale toward major OEM partnerships and international deployment."